☰

Neang S. Ly, Ph.D. - Publications

Affiliations: 
2014 Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
Tree Info Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Bulman ZP, Ly NS, Lenhard JR, Holden PN, Bulitta JB, Tsuji BT. Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa: Implications for Quorum Sensing Inhibition with Azithromycin. Antimicrobial Agents and Chemotherapy. PMID 28096154 DOI: 10.1128/Aac.00096-16  0.429
2016 Sharma R, Patel S, Abboud C, Diep J, Ly NS, Pogue JM, Kaye KS, Li J, Rao GG. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes. International Journal of Antimicrobial Agents. PMID 28040408 DOI: 10.1016/J.Ijantimicag.2016.10.025  0.477
2016 Wittau M, Paschke S, Kurlbaum M, Scheele J, Ly NS, Hemper E, Kornmann M, Henne-Bruns D, Bulitta JB. Population Pharmacokinetics and Target Attainment of Ertapenem in Plasma and Tissue Assessed via Microdialysis in Morbidly Obese Patients after Laparoscopic Visceral Surgery. Antimicrobial Agents and Chemotherapy. PMID 27795367 DOI: 10.1128/Aac.00952-16  0.337
2016 Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies. The Journal of Antimicrobial Chemotherapy. PMID 27494922 DOI: 10.1093/Jac/Dkw293  0.41
2016 Rao GG, Ly NS, Diep J, Forrest A, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii. International Journal of Antimicrobial Agents. PMID 27449542 DOI: 10.1016/j.ijantimicag.2016.06.006  0.441
2016 Ly NS, Bulman ZP, Bulitta JB, Baron C, Rao GG, Holden PN, Li J, Sutton MD, Tsuji BT. Optimization of Polymyxin B in Combination with Doripenem to Combat Mutator Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. PMID 26926641 DOI: 10.1128/Aac.02377-15  0.468
2015 Bulman ZP, Sutton MD, Ly NS, Bulitta JB, Holden PN, Nation RL, Li J, Tsuji BT. Emergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators. Antimicrobial Agents and Chemotherapy. 59: 4343-6. PMID 25918151 DOI: 10.1128/Aac.04629-14  0.442
2015 Ly NS, Bulitta JB, Rao GG, Landersdorfer CB, Holden PN, Forrest A, Bergen PJ, Nation RL, Li J, Tsuji BT. Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance. The Journal of Antimicrobial Chemotherapy. 70: 1434-42. PMID 25712313 DOI: 10.1093/Jac/Dku567  0.39
2015 Bulitta JB, Ly NS, Landersdorfer CB, Wanigaratne NA, Velkov T, Yadav R, Oliver A, Martin L, Shin BS, Forrest A, Tsuji BT. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling. Antimicrobial Agents and Chemotherapy. 59: 2315-27. PMID 25645838 DOI: 10.1128/Aac.04099-14  0.513
2014 Rao GG, Ly NS, Haas CE, Garonzik S, Forrest A, Bulitta JB, Kelchlin PA, Holden PN, Nation RL, Li J, Tsuji BT. New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease. Antimicrobial Agents and Chemotherapy. 58: 1381-8. PMID 24342636 DOI: 10.1128/Aac.00327-13  0.386
2013 Landersdorfer CB, Ly NS, Xu H, Tsuji BT, Bulitta JB. Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design. Antimicrobial Agents and Chemotherapy. 57: 2343-51. PMID 23478962 DOI: 10.1128/Aac.00092-13  0.52
2013 Soon RL, Ly NS, Rao G, Wollenberg L, Yang K, Tsuji B, Forrest A. Pharmacodynamic variability beyond that explained by MICs. Antimicrobial Agents and Chemotherapy. 57: 1730-5. PMID 23357773 DOI: 10.1128/Aac.01224-12  0.343
2012 Ly NS, Yang J, Bulitta JB, Tsuji BT. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 56: 3453-6. PMID 22470116 DOI: 10.1128/Aac.06380-11  0.387
2010 Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A, Forrest A, Bulitta JB, Tsuji BT. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 30: 1279-91. PMID 21114395 DOI: 10.1592/Phco.30.12.1279  0.425
2010 Bulitta JB, Yang JC, Yohonn L, Ly NS, Brown SV, D'Hondt RE, Jusko WJ, Forrest A, Tsuji BT. Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model. Antimicrobial Agents and Chemotherapy. 54: 2051-62. PMID 20211900 DOI: 10.1128/Aac.00881-09  0.554
2009 Bulitta JB, Ly NS, Yang JC, Forrest A, Jusko WJ, Tsuji BT. Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53: 46-56. PMID 18852268 DOI: 10.1128/Aac.00489-08  0.526
Show low-probability matches.